ACADIAN ASSET MANAGEMENT LLC

Position in FHTX — Foghorn Therapeutics Inc.

CIK 916542 Boston, MA

Position in FHTX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$189,265

+$9,389 QoQ

Shares Held

38,784

+3.1% QoQ

Ownership

0.065%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#45

of 102 holders

Holding Since

Sep 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $731,256,203 across 167 Biotechnology names. FHTX ranks #117 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	1,664,999	$188,744,286
2	REGN	Regeneron Pharmaceuticals, Inc.	157,440	$98,170,137
3	IMCR	Immunocore Holdings plc	1,209,894	$38,414,134
4	RIGL	Rigel Pharmaceuticals Inc	591,686	$23,146,756
5	EXEL	Exelixis, Inc.	421,444	$22,930,768
6	VRTX	Vertex Pharmaceuticals Inc / Ma	42,122	$20,923,261
7	TBPH	Theravance Biopharma, Inc.	1,174,910	$19,973,470
8	PRTA	Prothena Corp Public Ltd Co	2,010,645	$19,684,214

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$189,265	38,784	+3.1%	Shares	Defined	2026-08-13
2026-03-31	$179,876	37,631	+387.1%	Shares	Defined	2026-05-13
2025-12-31	$41,720	7,726	-18.6%	Shares	Defined	2026-02-10
2025-03-31	$34,656	9,495	-73.5%	Shares	Defined	2025-05-21
2024-12-31	$168,900	35,784	-15.5%	Shares	Defined	2025-02-11
2024-09-30	$394,436	42,367	0.0%	Shares	Defined	2024-11-12
2024-06-30	$243,610	42,367	0.0%	Shares	Defined	2024-08-06
2024-03-31	$284,282	42,367	+56.4%	Shares	Defined	2024-05-10
2023-03-31	$167,927	27,085	+15.1%	Shares	Defined	2023-05-11
2022-12-31	$150,191	23,541	+439.9%	Shares	Defined	2023-02-14
2022-09-30	$37,408	4,360	—	Shares	Defined	2022-11-14
No filing history on record for this holder in this stock.